Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes [Phase 4]
Pilot Phase 4 trial evaluating fenfluramine for various developmental and epileptic encephalopathies, including SYNGAP1 and STXBP1-related c…
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy [Phase 2]
Phase 2 pharmacokinetics study of oral 2-Deoxy-D-Glucose (2DG) in adults with epilepsy has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-14Clinical Trial Update: Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures [Phase 3]
Phase 3 trial evaluating lacosamide as add-on therapy for epileptic tonic-clonic seizures; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: A Double-Blind Trial to Evaluate Efficacy and Safety of Cannabidiol as an add-on Therapy for Treatment in Refractory Epilepsy [Phase 3]
A Phase 3 double-blind trial assessing cannabidiol as add-on therapy for refractory epilepsy; efficacy and safety results are not provided i…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Measuring Blood Flow in the Brain After Epileptic Activity [Phase 2]
Phase 2 clinical trial update evaluating blood flow measurement in the brain following epileptic activity.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-11-14Clinical Trial Update: Presurgical Motor Mapping With Transcranial Magnetic Stimulation (TMS) [NA]
Completed clinical trial evaluating presurgical motor mapping with transcranial magnetic stimulation (TMS) for epilepsy; results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With Epilepsy [Phase 3]
This Phase 3 trial evaluated the efficacy and safety of Brivaracetam in participants with epilepsy, including partial-onset seizures with or…
-
CLINICAL_TRIALS trial_result · 2023-11-01Clinical Trial Update: Manipulating and Optimizing Brain Rhythms for Enhancement of Sleep [NA]
A terminated clinical trial from Mayo Clinic investigating brain rhythm manipulation to enhance sleep, with posted results.
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: Bioequivalence Study of Sodium Valproate and Valproic Acid Tablets [Phase 4]
A Phase 4 clinical trial update assessing bioequivalence between sodium valproate and valproic acid tablets for epilepsy.
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy [Phase 2]
Phase 2 trial investigating add-on low-dose fenfluramine in Lennox-Gastaut epilepsy.
-
CLINICAL_TRIALS trial_result · 2023-09-15Clinical Trial Update: Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy [Phase 2]
Phase 2 pharmacokinetic study of an oral suspension of perampanel as adjunctive therapy in pediatric epilepsy subjects has completed with re…
-
CLINICAL_TRIALS trial_result · 2023-09-01Clinical Trial Update: High Frequency Oscillation in Pediatric Epilepsy Surgery [NA]
A completed clinical trial update on high frequency oscillation in pediatric epilepsy surgery; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Improvement Effect of Lacosamide and Levetiracetam on Cognitive in Alzheimer's Disease Patients With Epilepsy [Phase 4]
Phase 4 trial update assessing the improvement in cognitive function with lacosamide and levetiracetam in patients with Alzheimer's disease …
-
CLINICAL_TRIALS trial_result · 2023-06-23Clinical Trial Update: Repeated TMS at Low Frequencies to Reduce Seizure Occurrence [NA]
A clinical trial investigating repeated low-frequency TMS to reduce seizure occurrence was terminated; results were posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-05-15Clinical Trial Update: Safety, Tolerability, and Exploratory Efficacy of Adjunctive EQU-001 for Seizures in Adults With Epilepsy [Phase 2]
Phase 2 trial update reporting safety, tolerability, and exploratory efficacy of adjunctive EQU-001 for seizures in adults with epilepsy.
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: Electrical Neuromodulation for Focal Epilepsy [Phase 1, Phase 2]
An update on an electrical neuromodulation trial for epilepsy spanning Phase 1 and Phase 2 stages; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Cannabidiol in Children and Young Adults With Rare Disease-associated Severe Epilepsy [Phase 2]
Phase 2 clinical trial update evaluating cannabidiol in children and young adults with rare disease-associated severe epilepsy.
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: Low Frequency TMS for Depression in Epilepsy [NA]
Clinical trial update reporting completed study on low frequency transcranial magnetic stimulation for depression in epilepsy, with results …
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: A Dose Ranging Pilot Study for Intracerebroventricular (ICV) Delivery of Valproate in Subjects With Temporal Seizures [Phase 1, Phase 2]
A dose-ranging pilot study evaluating intracerebroventricular delivery of valproate in temporal seizures completed phases 1 and 2.
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: Ataluren for Nonsense Mutation in CDKL5 and Dravet Syndrome [Phase 2]
Phase 2 trial update for ataluren in nonsense mutation-related CDKL5 and Dravet syndrome (epilepsy) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-10Clinical Trial Update: Clinical Trial of the Effects of DHA in the Treatment of Seizure Disorders [Phase 2, Phase 3]
Phase 2/3 clinical trial investigating DHA for treatment-refractory epilepsy has been terminated.
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: A Study of GWP42006 in People With Focal Seizures - Part B [Phase 2]
Phase 2 trial update for GWP42006 in people with focal seizures (epilepsy) has completed.
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: A Study of GWP42006 in People With Focal Seizures - Part A [Phase 2]
Phase 2 trial update for GWP42006 in people with focal seizures (epilepsy) has been completed.
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy [Phase 2]
Phase 2 clinical trial update evaluating possible drug-drug interactions between stiripentol or valproate and cannabidiol in epilepsy patien…
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy [Phase 2]
Open-label extension to assess potential drug-drug interactions between stiripentol or valproate and cannabidiol in epilepsy patients (Phase…